Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "EY"

4648 News Found

Eye-Q upgrades advanced affordable eye care facility in Lucknow
Hospitals | May 09, 2026

Eye-Q upgrades advanced affordable eye care facility in Lucknow

The upgraded Rajajipuram centre now features enhanced retina services and advanced OCT technology


Agentic AI poised to reshape pharma operations beyond pilot-stage adoption: Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital
interviews | May 04, 2026

Agentic AI poised to reshape pharma operations beyond pilot-stage adoption: Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital

Enterprise-scale adoption in 2026 will be driven by domain-specific AI, compliance automation, and strong digital foundations across quality, manufacturing and regulatory workflows


Sankara Eye Hospital hosts ‘CSSD 360’ workshop on sterilisation and patient safety
Hospitals | May 04, 2026

Sankara Eye Hospital hosts ‘CSSD 360’ workshop on sterilisation and patient safety

Workshop focused on strengthening sterile processing standards, infection prevention, and CSSD best practices in healthcare settings


Bayer pushes stroke prevention drug forward in China as regulators accept key filing
News | May 02, 2026

Bayer pushes stroke prevention drug forward in China as regulators accept key filing

Stroke is the second-leading cause of death and the third-leading cause of disability worldwide


Pawan Varshney elevated to Director of Finance – South Asia at Cepheid
People | May 01, 2026

Pawan Varshney elevated to Director of Finance – South Asia at Cepheid

His appointment is expected to further strengthen the company’s financial governance and regional operational strategy across South Asia


Pfizer locks in long runway for blockbuster heart drug after key patent settlements
News | April 29, 2026

Pfizer locks in long runway for blockbuster heart drug after key patent settlements

The deals, tied to cases in the US District Court for the District of Delaware, effectively extend US patent protection for VYNDAMAX until June 1, 2031


Sun Pharma eyes biosimilars-led growth, Organon deal to build $12.4 billion global platform
News | April 28, 2026

Sun Pharma eyes biosimilars-led growth, Organon deal to build $12.4 billion global platform

On the generics and biosimilars front, the combined business is expected to benefit from Sun’s portfolio of more than 550 approved ANDAs across multiple dosage forms


Essilor Stellest lens positioned as key breakthrough in myopia control in India
News | April 28, 2026

Essilor Stellest lens positioned as key breakthrough in myopia control in India

The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025


LVPEI launches Eye and Brain Centre in Hyderabad with support from D. E. Shaw India
Hospitals | April 27, 2026

LVPEI launches Eye and Brain Centre in Hyderabad with support from D. E. Shaw India

The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders


Merck wins FDA priority review for KEYTRUDA bladder cancer combo expansion
Clinical Trials | April 22, 2026

Merck wins FDA priority review for KEYTRUDA bladder cancer combo expansion

If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev